Priority Date: 08.03.11 (EP 20110305241)
BRANCHED OXATHIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND USE THEREOF
- Application ID: EP12707339
- Status: █ NO OPPOSITION FILED WITHIN TIMELIMIT
Applicant
Technology Company
Attorney
Specialization
This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Sanofi-Aventis Deutschland GmbH is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.
Timeline
- 08.03.2011 - Priority Date (EP 20110305241)
- 13.09.2012 - Publication A1 (WO2012120053)
- 15.01.2014 - Publication A1 (EP2683704)
- 17.12.2014 - Publication B1 (EP2683704)